Most Recent
Generic drug maker Sun Pharma has succeeded in invalidating Otsuka Pharmaceutical’s patent for an injectable, controlled release form of the Japanese drug maker's top-selling antipsychotic Abilify.
Ahead of an eight-week trial in an investor class action in July, ratings agency S&P has lost its bid to throw out the entirety of the expert evidence in the case.
Trial in a class action against Suncorp unit AAI over add-on insurance has been delayed as Maurice Blackburn works to secure a NAB bank guarantee to satisfy a $1.7 million security for costs order.
Construction PRO
A developer is on the hook for $2.6 million after a court found he misappropriated a tax refund associated with a scheme to develop property in Spring Farm, NSW and put it towards a luxury Sydney home in his wife’s name.
A judge has rejected HSU secretary Diana Asmar's argument that a case against her over an alleged $2.7 million false invoicing scheme should be stayed because criminal charges were “on the cards”.
A trans woman who won her discrimination case against the Giggle for Girls app and its CEO Sal Grover has launched a cross-appeal against the landmark decision.
A class action against Exactech over allegedly faulty joint implants has been stayed pending its US-based parent company’s bankruptcy proceedings.
The High Court has overturned a controversial decision that put a judge on the hook for a man’s false imprisonment, finding that all judges are immune from civil suits for acts done in the performance of their judicial duties.
A class action against BHP can include in the group member definition investors who bought shares on secondary platforms, but the change can't apply retroactively.
In deciding an evidentiary dispute in a shareholder class action against building materials giant Boral, a judge has sounded off over the increasing costs of expert evidence produced in group proceedings.